Gursharan K Dogra

Summary

Affiliation: University of Western Australia
Country: Australia

Publications

  1. ncbi Statin therapy improves brachial artery endothelial function in nephrotic syndrome
    Gursharan K Dogra
    Department of Medicine and Western Australian Heart Research Institute, University of Western Australia, Australia
    Kidney Int 62:550-7. 2002
  2. ncbi Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study
    Gursharan K Dogra
    Department of Medicine, University of Western Australia, Perth, Western Australia
    J Am Soc Nephrol 13:2133-9. 2002
  3. ncbi Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome
    Gursharan K Dogra
    Department of Medicine and Western Australian Heart Research Institute, University of Western Australia, Perth, Western Australia, Australia
    Nephrol Dial Transplant 17:2220-5. 2002
  4. ncbi Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria
    G K Dogra
    School of Medicine and Pharmacology, Royal Perth Hospital Unit, Western Australian Heart Research Institute, University of Western Australia, Perth, Western Australia
    Diabet Med 22:239-42. 2005
  5. ncbi Rosiglitazone does not improve vascular function in subjects with chronic kidney disease
    Doris T Chan
    School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth, Australia
    Nephrol Dial Transplant 26:3543-9. 2011
  6. ncbi Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease
    Esther M M Ooi
    Metabolic Research Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia
    J Lipid Res 52:794-800. 2011
  7. ncbi Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials
    Doris T Chan
    Metabolic Research Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia 6000, Australia
    Atherosclerosis 196:823-34. 2008
  8. ncbi Vascular function of the peripheral circulation in patients with nephrosis
    G F Watts
    Department of Medicine and Western Australian Heart Research Institute, University of Western Australia, Australia
    Kidney Int 60:182-9. 2001
  9. ncbi Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III
    Doris T Chan
    School of Medicine Pharmacology, Royal Perth Hospital Unit, University of Western Australia, WA, Australia
    J Lipid Res 50:2524-31. 2009
  10. ncbi Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality
    Wai H Lim
    Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, SA, Australia
    Perit Dial Int 31:663-71. 2011

Collaborators

Detail Information

Publications10

  1. ncbi Statin therapy improves brachial artery endothelial function in nephrotic syndrome
    Gursharan K Dogra
    Department of Medicine and Western Australian Heart Research Institute, University of Western Australia, Australia
    Kidney Int 62:550-7. 2002
    ..Patients with nephrotic syndrome have impaired endothelial function probably related to dyslipidemia. This study evaluated the effects of statin therapy on dyslipidemia and endothelial function in patients with nephrotic syndrome...
  2. ncbi Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study
    Gursharan K Dogra
    Department of Medicine, University of Western Australia, Perth, Western Australia
    J Am Soc Nephrol 13:2133-9. 2002
    ..Before this technique is adopted, these preliminary observations warrant replication in future studies that will examine the efficacy and safety of lower doses of gentamicin or alternative agents with a reduced potential for toxicity...
  3. ncbi Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome
    Gursharan K Dogra
    Department of Medicine and Western Australian Heart Research Institute, University of Western Australia, Perth, Western Australia, Australia
    Nephrol Dial Transplant 17:2220-5. 2002
    ..In this study our aim was to assess the potential roles of insulin resistance, plasma non-esterified fatty acids (NEFAs) and inflammation in endothelial dysfunction in NS patients...
  4. ncbi Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria
    G K Dogra
    School of Medicine and Pharmacology, Royal Perth Hospital Unit, Western Australian Heart Research Institute, University of Western Australia, Perth, Western Australia
    Diabet Med 22:239-42. 2005
    ..We therefore examined the effects of atorvastatin on brachial artery endothelial dysfunction in these patients...
  5. ncbi Rosiglitazone does not improve vascular function in subjects with chronic kidney disease
    Doris T Chan
    School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth, Australia
    Nephrol Dial Transplant 26:3543-9. 2011
    ..This study examines the effect of RSG on vascular function in patients with CKD...
  6. ncbi Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease
    Esther M M Ooi
    Metabolic Research Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia
    J Lipid Res 52:794-800. 2011
    ..05 for all). Altered plasma apoC-III metabolism is a feature of dyslipidemia in moderate CKD. Modification of apoC-III catabolism may be an important therapeutic target for reducing cardiovascular disease risk in moderate CKD...
  7. ncbi Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials
    Doris T Chan
    Metabolic Research Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia 6000, Australia
    Atherosclerosis 196:823-34. 2008
    ..Because of increased risk of toxicity, particularly myopathy, statins and other lipid-regulating agents should be used cautiously in CKD and renal transplant recipients...
  8. ncbi Vascular function of the peripheral circulation in patients with nephrosis
    G F Watts
    Department of Medicine and Western Australian Heart Research Institute, University of Western Australia, Australia
    Kidney Int 60:182-9. 2001
    ..Endothelial dysfunction, an early phase of atherogenesis that manifests as impaired flow-mediated dilation (FMD) of the peripheral circulation, may link these associations...
  9. ncbi Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III
    Doris T Chan
    School of Medicine Pharmacology, Royal Perth Hospital Unit, University of Western Australia, WA, Australia
    J Lipid Res 50:2524-31. 2009
    ..Altered apoC-III metabolism may contribute to dyslipidemia in CKD, and this requires further investigation...
  10. ncbi Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality
    Wai H Lim
    Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, SA, Australia
    Perit Dial Int 31:663-71. 2011
    ..The reluctance of elderly ESKD patients to consider PD may be related to a perception that PD is associated with greater rates of complications. In the present study, we compared outcomes between younger and older PD patients...